Skip to content

Hypotension in Children With Down Syndrome With Anesthesia Induction

Incidence of Hypotension in Children With Down Syndrome During Induction of Anesthesia With Sevoflurane

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04603469
Enrollment
45
Registered
2020-10-26
Start date
2021-05-26
Completion date
2021-10-28
Last updated
2022-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypotension on Induction

Brief summary

Children generally undergo induction of anesthesia by inhalation of sevoflurane. Children with Down Syndrome experience bradycardia with induction of anesthesia using sevoflurane. It is unknown if this bradycardia is isolate or results in hypotension, thus requiring treatment. Isolate bradycardia without hypotension does not require treatment and should be avoided as many of these patients have underlying cardiac anomalies.

Detailed description

Children generally undergo induction of anesthesia by inhalation of sevoflurane. This is particularly relevant for children with developmental delays as to avoid placement of an IV while awake. However, children with Down Syndrome experience bradycardia with induction of anesthesia using sevoflurane. It is unknown if this bradycardia is isolate or results in hypotension, thus requiring treatment. Isolate bradycardia without hypotension does not require treatment and should be avoided as many of these patients have underlying cardiac anomalies.

Interventions

measurement of blood pressure during induction of general anesthesia

Sponsors

Baylor College of Medicine
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Weeks to 18 Years
Healthy volunteers
No

Inclusion criteria

Children \<18 years old Requiring general anesthesia with inhalation induction Down syndrome ASA physical classification 1-3

Exclusion criteria

Patients \>18 years of age Patients without down syndrome Cyanotic congenital heart disease Use of antihypertensive medications Pulmonary hypertension patients undergoing intravenous induction of anesthesia ASA physical classification other than 1-3 emergency procedure

Design outcomes

Primary

MeasureTime frameDescription
Assessment of non-invasive blood pressure during induction5 minutesnon invasive blood pressure during induction (systolic, diastolic and Mean pressures)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026